Anncross Healthcare And Research India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 15 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 17.24%
- Profit Growth -2923.02%
- Ebitda -637.46%
- Net Worth -27.35%
- Total Assets 1.76%
About Anncross Healthcare And Research India
Anncross Healthcare And Research India Private Limited (AHARIPL) is a Private Limited Indian Non-Government Company incorporated in India on 31 December 2009 and has a history of 15 years and one month. Its registered office is in Coimbatore, Tamil Nadu, India.
The Company is engaged in the Musical Instruments Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Bhaskaran Renakumar and Vijayakumari Krishnanadar serve as directors at the Company.
Company Details
-
Location
Coimbatore, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85110TZ2009PTC015721
-
Company No.
015721
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
31 Dec 2009
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Coimbatore
Industry
Who are the key members and board of directors at Anncross Healthcare And Research India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhaskaran Renakumar
|
Director | 31-Dec-2009 | Current |
|
Vijayakumari Krishnanadar
|
Director | 31-Dec-2009 | Current |
Financial Performance of Anncross Healthcare And Research India.
Anncross Healthcare And Research India Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 17.24% increase. The company also saw a substantial fall in profitability, with a 2923.02% decrease in profit. The company's net worth observed a substantial decline by a decrease of 27.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anncross Healthcare And Research India?
In 2017, Anncross Healthcare And Research India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Anncross Healthcare And Research India?
Unlock and access historical data on people associated with Anncross Healthcare And Research India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anncross Healthcare And Research India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anncross Healthcare And Research India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.